Modelling the number of avoidable new cancer cases in France attributable to alcohol consumption by following official recommendations: a simulation study.
Alcohol
France
attributable fraction
cancer
incidence
simulation
Journal
Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
revised:
20
10
2020
received:
10
07
2020
accepted:
20
01
2021
pubmed:
11
2
2021
medline:
1
10
2021
entrez:
10
2
2021
Statut:
ppublish
Résumé
To predict the effects of perfect adherence to the French alcohol consumption guidelines, a maximum of 10 standard alcoholic drinks per week with no more than two standard alcoholic drinks per day, during a 36-year period (2014-50). This simulation study is an adaption of the Sheffield Alcohol Policy Model. The dose-response relationship between alcohol consumption and alcohol-attributable cancer risks was defined by cancer site-specific risk functions, each modelled as a continuous risk. These estimates were used to compute the potential impact fraction (PIF) associated with alcohol consumption by cancer site. The French general adult population during a 36-year period (2014-50). For the baseline scenario, the current distribution of consumption levels, the counterfactual scenario and perfect adherence to the French alcohol consumption guidelines, we generated for each gender and age group 1000 randomly distributed alcohol consumption values from calibrated group-specific gamma distribution. The predicted number of new cancer cases among men and women in France between 2015 and 2050 that could have been prevented by following the French government's alcohol consumption guidelines. The simulation predicted that perfect adherence to the French government's alcohol consumption guidelines would prevent, on average, an estimated 15 952 cancer cases per year after the PIF reached its full effect, which would have represented 4.5% of new cancer cases in 2015. The number of averted cancer cases over the study period were highest for oral cavity, oropharynx and hypopharynx cancer (respectively, 118 462, 95% CI = 113 803-123 022 and 11 167, 95% CI = 10 149-12 229] for men and women; liver and intrahepatic bile ducts cancer (123 447, 95% CI = 112 581-133 404 and 2825, 95% CI = 2208,4095); colorectal cancer (89 859, 95% CI = 84 651-95 355 and 12 847, 95% CI = 11 545-14 245); and female breast cancer (61 649, 95% CI = 56 330-67 452). This simulation study of the French general population predicted that perfect adherence to the French government's alcohol consumption guidelines (no more than 10 standard alcoholic drinks per week and two per day) would prevent almost 16 000 cancer cases per year.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2316-2325Informations de copyright
© 2021 Society for the Study of Addiction.
Références
Richard J.-B., Palle C., Guignard R., Nguyen-Thanh V., Beck F., Arwidson P. La consommation d'alcool en France en 2014 [Alcohol consumption in France in 2014]. Évolution 2015; 32: 1-6.
Bonaldi C., Hill C. La mortalité attribuable à l'alcool en France en 2015 [Mortality attributable to alcohol in France in 2015]. Bull épidémiol hebd 2019; 2019: 97-108.
Institute for Health Metrics and Evaluation. France. Institute for Health Metrics and Evaluation. 2020. Available at: http://www.healthdata.org/france (accessed 3 June 2020).
Shield K. D., Marant Micallef C., Hill C., Touvier M., Arwidson P., Bonaldi C., et al. New cancer cases in France in 2015 attributable to different levels of alcohol consumption: alcohol-attributable cancer cases in France. Addiction 2018; 113: 247-256.
Praud D., Rota M., Rehm J., Shield K., Zatoński W., Hashibe M., et al. Cancer incidence and mortality attributable to alcohol consumption: alcohol attributable cancers. Int J Cancer 2016; 138: 1380-1387.
Global Burden of Disease (GBD) 2017 Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet 2018; 392: 1789-1858.
Santé publique France, Institut national du cancer. Avis d'experts Relatif à l'évolution Du Discours Public En Matière de Consommation d'alcool En France. Santé publique France [Expert opinion on the evolution of public discourse on alcohol consumption in France organized by Public Health France and the National Cancer Institute]. 2017. Available at: https://www.santepubliquefrance.fr/les-actualites/2017/avis-d-experts-relatif-a-l-evolution-du-discours-public-en-matiere-de-consommation-d-alcool-en-france-organise-par-sante-publique-france-et-l-inca (accessed 4 June 2020).
Rehm J., Lachenmeier D. W., Room R. Why does society accept a higher risk for alcohol than for other voluntary or involuntary risks? BMC Med 2014; 12: 189.
Purshouse R., Brennan A., Latimer N., Archer R. J., Angus C. R., Preston L. R. et al. Modelling to Assess the Effectiveness and Cost-Effectiveness of Public Health Related Strategies and Interventions to Reduce Alcohol Attributable Harm in England Using the Sheffield Alcohol Policy Model version 2.0. Sheffield, UK: University of Sheffield; 2000. Available at: https://www.nice.org.uk/guidance/ph24/evidence/economic-modelling-report-371533357(accessed 4 June 2020).
Brennan A., Meier P., Purshouse R., Rafia R., Meng Y., Hill-Macmanus D., et al. The Sheffield alcohol policy model-a mathematical description. Health Econ 2015; 24: 1368-1388.
Brennan A., Meier P., Purshouse R., Rafia R., Meng Y., Hill-Macmanus D. Developing policy analytics for public health strategy and decisions-the Sheffield alcohol policy model framework. Ann Oper Res 2016; 236: 149-176.
Bagnardi V., Rota M., Botteri E., Tramacere I., Islami F., Fedirko V., et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer 2015; 112: 580-593.
Institut national de la statistique et des études économiques (INSEE). Évolution et structure de la population en 2014 [Evolution and structure of the population in 2014]. Insee.fr. 2017. Available at: https://www.insee.fr/fr/statistiques/2874204?geo=METRO-1%26;sommaire=2874226 (accessed 4 June 2020).
Inserm CépiDc. Interrogation des données sur les causes de décès de 1980 à 2016 [Death Statistics by Cause from 1980 to 2016]. Available at: http://cepidc?data.inserm.fr/inserm/html/index2.htm (accessed 26 January 2020).
Binder-Foucard F., Belot A., Delafosse P., Remontet L., Woronoff A.-S., Bossard N. Estimation nationale de l'incidence et de la mortalité par cancer en France entre 1980 et 2012: étude à partir des registres des cancers du réseau FRANCIM [National estimate of cancer incidence and mortality in France between 1980 and 2012. Study based on cancer registers from the FRANCIM network]. Institut e eille sanitaire. 2013. Available at: https://www.santepubliquefrance.fr/docs/estimation-nationale-de-l-incidence-et-de-la-mortalite-par-cancer-en-france-entre-1980-et-2012.-etude-a-partir-des-registres-des-cancers-du-reseau (accessed 23 March 2020).
Institut national de la statistique et des études économiques (INSEE). The 2012 Employment Survey. INSEE.fr. Available at: https://www.insee.fr/fr/metadonnees/source/operation/s1085/presentation (accessed 23 March 2020).
Richard J.-B., Cogordan C., Merle S. Baromètre Santé DOM 2014 [DOM 2014 health barometer]. Baromètres santé 2016:1-16. Available at: santepubliquefrance.fr/determinants-de-sante/alcool/documents/barometre-sante-dom-2014.-consommations-d-alcool
Richard J-B, Gautier A, Guignard R, Léon C, Beck F. Méthode d'enquête du Baromètre Santé 2014. Baromètres santé; 2015:1-26.Available at: https://www.santepubliquefrance.fr/docs/methode-d-enquete-du-barometre-sante-2014 (accessed 23 March 2020).
Observatoire français des drogues et des toxicomanies (OFDT). Quantité d'alcool mis en vente par habitant âgé de 15 ans et plus depuis 1961 (en litres équivalents d'alcool pur) [Quantity of alcohol sold per inhabitant aged 15 and over since 1961 (in equivalent liters of pure alcohol]. OFDT.fr. Available at: https://www.ofdt.fr/statistiques-et-infographie/series-statistiques/alcool-evolution-des-quantites-consommees-par-habitant-age-de-15-ans-et-plus-depuis-1961-en-litres-equivalents-dalcool-pur/ (accessed 4 June 2020).
Rehm J., Kehoe T., Gmel G., Stinson F., Grant B., Gmel G. Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the US example. Popul Health Metr 2010; 8: 3.
Rubinstein R. Y., Kroese D. P. Simulation and the Monte Carlo Method, 3rd edn. Hoboken, NJ: John Wiley & Sons, Inc.; 2017.
Kehoe T., Gmel G., Shield K. D., Gmel G., Rehm J. Determining the best population-level alcohol consumption model and its impact on estimates of alcohol-attributable harms. Popul Health Metr 2012; 10: 6.
Jones L. A., Bellis M., Dedman D., Sumnall H., Tocque K. Alcohol-Attributable Fractions for England: Alcohol-Attributable Mortality and Hospital Admissions. Liverpool: Centre for Public Health; 2008.
Purshouse R. C., Meier P. S., Brennan A., Taylor K. B., Rafia R. Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological model. Lancet 2010; 375: 1355-1364.
Grundy A., Poirier A. E., Khandwala F., McFadden A., Friedenreich C. M., Brenner D. R. Cancer incidence attributable to alcohol consumption in Alberta in 2012. Can Med Assoc J Open 2016; 4: e507-e514.
Zakhari S., Li T.-K. Determinants of alcohol use and abuse: impact of quantity and frequency patterns on liver disease. Hepatology 2007; 46: 2032-2039.
Spach M. Enjeux économiques et politiques publiques de lutte contre la consommation nocive d'alcool en France [Economic issues and public policies to combat harmful alcohol consumption in France]. Sante Publique 2016; 28: 461-470.
Rose G. Sick individuals and sick populations. Int J Epidemiol 2001; 30: 427-432.
Meier P. S., Purshouse R., Brennan A. Policy options for alcohol price regulation: the importance of modelling population heterogeneity. Addiction 2010; 105: 383-393.